Events2Join

2018 could be a record year for blockbuster drugs


About the Evergreen Drug Patent Database - UC Law Sites

Rather than creating new medicines, pharmaceutical companies are largely recycling and repurposing old ones. Specifically, 78% of the drugs associated with new ...

How FDA Failures Contributed to the Opioid Crisis | Journal of Ethics

Even in safety trials for opioid drugs approved by the FDA, serious adverse events—including respiratory depression, death, and drug diversion—are common.21, 22 ...

History - Pfizer

Pfizer's Sharing the Care, the industry's premier drug-donation program, is launched. Sharing the Care provides medicines to more than one million eligible low- ...

Drug Pricing Investigation - Document Repository

Drug Prices (Part III): Testimony from AbbVie CEO Richard Gonzalez” (May 18, 2021). 72 AbbVie, Making Medicines Accessible (online at www.abbvie ...

Web Exclusives - PharmaTimes

2018 could be a record year for blockbuster drugs ... Gamification: the next disruption in pharma? 6th Apr 2018. How bringing the ...

Why 90% of clinical drug development fails and how to improve it?

Although it is correct that only free drugs could engage their molecular ... Kinase drug discovery 20 years after imatinib: progress and future directions.

DOSE OF REALITY: BIG PHARMA SETS DRUG PRICES, HIKES ...

According to a recent Reuters analysis, the median annual price among new drugs approved by the U.S. Food and Drug Administration (FDA) in 2023 ...

Company history timeline - Bristol Myers Squibb

FIRST DRUG REGULATIONS. With Dr. Squibb's untiring concern for the use of quality drugs, he justifies his criticism of the American ...

The Last Mega Blockbuster Drug: Goodbye Humira, Hello Future

First launched in 1997, Lipitor is a cholesterol-lowering drug that generated over $100 billion for Pfizer during its 14-year patent-protected ...

Drug Prices And Innovation - Forbes

If a drug company tries to “play it safe” by working on familiar drugs, they will almost certainly not be able to compete against the medicines ...

How Big Pharma Rigged the Patent System - The American Prospect

One legal strategy Big Pharma uses is filing dozens or even hundreds of patents on the same drug. An Initiative for Medicines, Access, and ...

Biotech from bust to boom - Bay Bridge Bio

Precision medicine. Another tailwind for drug development, specifically for cancer and rare disease drugs, was the rise of “precision medicine”.

A history of the pharmaceutical industry - Pharmaphorum

In 1977, Tagamet, an ulcer medication, became the first ever “blockbuster” drug, earning its manufacturers more than $1 billion a year and its ...

A History of Impact - AbbVie

Our first AbbVie-created medicine was approved · AbbVie medicines impact over 30 million patients around the world · AbbVie announced novel collaboration on aging ...

List of largest selling pharmaceutical products - Wikipedia

^ "Top 15 Best-Selling Drugs of 2018". GEN - Genetic Engineering and ... ^ "Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs?

First-time launchers in the pharmaceutical industry | McKinsey

Growing numbers of small biopharma companies are launching their new drugs themselves rather than relying on big companies to do it for them ...

Sanofi Rating Report - 2018 Sep - Scope Group

group's product portfolio, with five blockbuster drugs, and long-term track record of stable ... pharmaceutical pipeline than from a year ago.

Novo Nordisk (Ozempic) - Acquired Podcast

We had this great heyday 30 years ago of small molecule drugs that you could ... The fact that on the blockbuster drugs, the companies earn ...

Medicaid's Prescription Drug Benefit: Key Facts - KFF

... blockbuster” drugs. Policymakers' actions to control drug spending ... drugs will decline over time due to competition. Trends in ...

How Roche passed on a potential $14billion-a-year weight-loss pill

The Swiss company had the first option on a drug that could now become a leading anti-obesity treatment. ... drugs land on your desk and become a ...